| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TERT 5' regulatory region | 0.464 | 0.731 |
|
disease | 0.100 | None | 0.932 | 44 | 0 | 2013 | 2019 | |||||||||
|
microRNA 146b | 0.496 | 0.769 |
|
disease | 0.100 | None | 1.000 | 27 | 0 | 2008 | 2019 | |||||||||
|
microRNA 222 | 0.486 | 0.808 |
|
disease | 0.100 | None | 0.867 | 15 | 0 | 2007 | 2019 | |||||||||
|
Hashimoto thyroiditis | 0.505 | 0.731 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2003 | 2019 | |||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2005 | 2019 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.100 | None | 0.900 | 10 | 1 | 2008 | 2018 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2013 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2005 | 2017 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2005 | 2017 | |||||||||
|
microRNA 204 | 0.487 | 0.808 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2015 | 2019 | |||||||||
|
microRNA 451a | 0.505 | 0.769 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2013 | 2019 | |||||||||
|
microRNA 144 | 0.500 | 0.769 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2018 | |||||||||
|
GAS8 antisense RNA 1 | 0.751 | 0.192 |
|
disease | 0.350 | None | 1.000 | 5 | 1 | 2016 | 2019 | |||||||||
|
papillary thyroid carcinoma susceptibility candidate 3 | 0.722 | 0.385 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2012 | 2017 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2002 | 2015 | |||||||||
|
nuclear paraspeckle assembly transcript 1 | 0.502 | 0.769 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2018 | 2020 | |||||||||
|
hypertrichosis 2 (generalized, congenital) | 0.392 | 0.808 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2012 | |||||||||
|
microRNA 141 | 0.497 | 0.808 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2013 | 2019 | |||||||||
|
microRNA 15a | 0.482 | 0.808 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2013 | 2019 | |||||||||
|
microRNA 30a | 0.478 | 0.808 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | |||||||||
|
microRNA 485 | 0.593 | 0.731 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2017 | 2020 | |||||||||
|
microRNA 486-1 | 0.521 | 0.808 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2019 | |||||||||
|
urothelial cancer associated 1 | 0.512 | 0.808 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2018 | 2019 | |||||||||
|
papillary thyroid carcinoma susceptibility candidate 2 | 0.751 | 0.231 |
|
disease | 0.030 | None | 1.000 | 3 | 5 | 2015 | 2017 |